Stents

This channel includes news and new technology innovations for stents, also called vascular scaffolds. Stents are used to help prop open a vessel treated by balloon angioplasty because of the barotrauma caused by the extreme stretching of vessel walls. The stent enables to vessel to heal in an open position with collapsing. Drug eluting stents (DES) are coated in anti-proliferative drugs to precent scar tissue growth which can cause restenosis and occlude the vessel. DES require antiplatelet therapy because the drug carrier polymer on DES can cause thrombus inside the stent, even years after treatment, which is why bare metal stents are still used in some patients. This page includes news on coronary stents, carotid stents, peripheral stents, bioresorbable stents, and renal stents. 

News | Stents Peripheral

July 14, 2017 — Intact Vascular Inc. announced the U.S. Food and Drug Administration (FDA) approved an Investigational ...

Home July 14, 2017
Home
News

June 12, 2017 – The Medtronic Resolute Onyx Drug-Eluting Stent (DES) met its primary endpoint of target lesion failure ...

Home June 12, 2017
Home
News | Stents Drug Eluting

May 12, 2017 — PinnacleHealth CardioVascular Institute enrolled the first patient in Pennsylvania in a trial assessing ...

Home May 12, 2017
Home
Technology | Stents Drug Eluting

May 1, 2017 — The U.S. Food and Drug Administration (FDA) approved Medtronic’s Resolute Onyx Drug-eluting Stent (DES) ...

Home May 01, 2017
Home
Videos | Stents Drug Eluting

This video, provided by Medtronic, demonstrates the Resolute Onyx coronary stent. It was cleared by the FDA and launched ...

Home May 01, 2017
Home
News | Stents Peripheral

April 28, 2017 — Biotronik’s Pulsar-18 bare metal stent (BMS) has yielded high primary patency in a real-world setting ...

Home April 28, 2017
Home
News | Stents Bifurcation

March 31, 2017 — Tryton Medical Inc. recently announced that the first U.S. commercial case using the Tryton Side Branch ...

Home March 31, 2017
Home
Videos | Stents Bioresorbable

Stephen Ellis, M.D., professor of medicine and director of interventional cardiology at Cleveland Clinic, discusses the ...

Home March 30, 2017
Home
BVS, Absorb stent, bioresorbable scaffold, ABSORB III data, ABSORB III results
Feature | Stents Bioresorbable | Dave Fornell

March 21, 2017 — In the late-breaking ABSORB III Trial two year results presented at the American College of Cardiology ...

Home March 21, 2017
Home
News | Stents Peripheral

March 16, 2017 — W. L. Gore & Associates Inc. recently announced the Health Canada approval of the Gore Tigris Vascular ...

Home March 16, 2017
Home
Videos | Stents Bifurcation

This video, provided by Tryton, demonstrates the implantation of the Tryton Side Branch Stent. It became the first ...

Home March 06, 2017
Home
Technology | Stents Bifurcation

March 6, 2017 – The U.S. Food and Drug Administration (FDA) has granted pre-market approval (PMA) for the Tryton Side ...

Home March 06, 2017
Home
News | Stents Drug Eluting

March 3, 2017 — Biosensors International Group Ltd. announced in February enrollment of the first patient in LEADERS ...

Home March 03, 2017
Home
News | Stents Peripheral

March 2, 2017 — Intact Vascular Inc. announced in February that its Tack Optimized Balloon Angioplasty II Below the Knee ...

Home March 02, 2017
Home
Technology | Stents

March 2, 2017 — The U.S. Food and Drug Administration (FDA) cleared CeloNova BioSciences Inc. first-in-class Cobra PzF ...

Home March 02, 2017
Home
Subscribe Now